Fig. 1

Schematic of the study design. COPD, chronic obstructive pulmonary disease; DPI, dry powder inhaler; ICS, inhaled corticosteroid; LABA, long-acting \(\:\beta\:\)2 agonist; MDI, metered dose inhaler
Schematic of the study design. COPD, chronic obstructive pulmonary disease; DPI, dry powder inhaler; ICS, inhaled corticosteroid; LABA, long-acting \(\:\beta\:\)2 agonist; MDI, metered dose inhaler